Latest Insider Transactions at Maia Biotechnology, Inc. (MAIA)
This section provides a real-time view of insider transactions for Maia Biotechnology, Inc. (MAIA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MAIA Biotechnology, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MAIA Biotechnology, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 13
2022
|
Ramiro Guerrero Director |
BUY
Open market or private purchase
|
Direct |
8,798
+2.87%
|
$26,394
$3.85 P/Share
|
|
Aug 30
2022
|
Ramiro Guerrero Director |
BUY
Open market or private purchase
|
Direct |
283
+0.1%
|
$849
$3.97 P/Share
|
|
Aug 24
2022
|
Sergei Gryaznov Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+22.47%
|
$10,000
$1.8 P/Share
|
|
Aug 01
2022
|
Stan Smith Director |
BUY
Other acquisition or disposition
|
Indirect |
7,200
+1.41%
|
-
|
|
Aug 01
2022
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
200,000
+28.73%
|
$1,000,000
$5.0 P/Share
|
|
Aug 01
2022
|
Mihail Obrocea Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+3.56%
|
$5,000
$5.0 P/Share
|
|
Aug 01
2022
|
Vlad Vitoc Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
6,000
+0.75%
|
$30,000
$5.0 P/Share
|
|
Aug 01
2022
|
Joseph F Mcguire Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$25,000
$5.0 P/Share
|
|
Aug 01
2022
|
Laurentiu Vlad Director |
BUY
Open market or private purchase
|
Direct |
5,000
+1.31%
|
$25,000
$5.0 P/Share
|
|
Aug 01
2022
|
Cristian Luput Director |
BUY
Open market or private purchase
|
Direct |
500
+0.18%
|
$2,500
$5.0 P/Share
|
|
Aug 01
2022
|
Ngar Yee Louie Director |
BUY
Open market or private purchase
|
Direct |
20,000
+2.11%
|
$100,000
$5.0 P/Share
|
|
Aug 01
2022
|
Sergei Gryaznov Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+10.9%
|
$15,000
$5.0 P/Share
|
|
Aug 01
2022
|
Steven M Chaouki Director |
BUY
Other acquisition or disposition
|
Direct |
8,000
+12.85%
|
-
|
|
Aug 01
2022
|
Steven M Chaouki Director |
BUY
Open market or private purchase
|
Direct |
5,000
+9.76%
|
$25,000
$5.0 P/Share
|
|
Aug 01
2022
|
Ramiro Guerrero Director |
BUY
Open market or private purchase
|
Direct |
20,000
+6.49%
|
$100,000
$5.0 P/Share
|
|
Jul 28
2022
|
Ramiro Guerrero Director |
BUY
Open market or private purchase
|
Direct |
9,000
+3.24%
|
$36,000
$4.0 P/Share
|